Abstract Remote monitoring has undergone a paradigm shift from passive data collection to intelligent, predictive, and decentralized systems. Recent advances in artificial intelligence (AI), flexible wearable electronics, and edge computing are enabling real-time, continuous health surveillance outside clinical settings. This article reviews key technological breakthroughs in the field, including AI-powered anomaly detection, multimodal sensor fusion, and low-power wireless communication protocols. We highlight significant studies published in 2023–2025 that demonstrate the clinical utility of remote monitoring for chronic disease management, post-surgical recovery, and early infection detection. The integration of federated learning and digital twins is further enhancing data privacy and personalized intervention. Despite challenges in interoperability, regulatory approval, and health equity, the convergence of these technologies promises a future where remote monitoring is a cornerstone of precision medicine.

1. Introduction The global healthcare burden of chronic diseases, aging populations, and pandemic preparedness has accelerated the adoption of remote patient monitoring (RPM) systems. Traditional RPM relied on periodic transmission of vital signs via Bluetooth-enabled devices, but these approaches suffered from high latency, limited context awareness, and poor patient adherence. The past two years have witnessed a transformation driven by three pillars: (1) miniaturized, skin-mountable sensors with milliwatt power consumption; (2) on-device AI that processes data locally to reduce cloud dependency; and (3) novel communication protocols such as LoRaWAN and NB-IoT that enable long-range, low-power connectivity. This article synthesizes the latest research to outline how these innovations are reshaping remote monitoring.

2. AI-Enabled Anomaly Detection and Predictive Analytics A major breakthrough is the deployment of lightweight neural networks directly on wearable devices. For instance, a 2024 study by Chen et al. introduced a spiking neural network (SNN) architecture for electrocardiogram (ECG) analysis on a microcontroller unit (MCU) with only 256 KB of RAM. The SNN achieved 94.3% accuracy in detecting atrial fibrillation while consuming 120 µW—a 40-fold energy reduction compared to conventional convolutional networks. This enables continuous arrhythmia monitoring without frequent battery recharging.

Beyond single-vital-sign analysis, multimodal AI models are fusing data from accelerometers, photoplethysmography (PPG), and temperature sensors to predict clinical deterioration. A landmark trial by Rodriguez-Vega et al. (2025) used a transformer-based model trained on 12,000 hours of home monitoring data to forecast sepsis onset 6–8 hours before clinical symptoms, with a sensitivity of 91% and a false alarm rate of 0.8 per day. Such models leverage attention mechanisms to identify subtle patterns in heart rate variability and respiratory rate that precede systemic infection.

3. Wearable Sensor Innovations: From Rigid to Stretchable The form factor of sensors has evolved from rigid patches to stretchable, breathable substrates. Recent progress in graphene-based e-textiles has produced smart garments that measure ECG, electromyography (EMG), and sweat biomarkers simultaneously. In 2024, Park and colleagues demonstrated a washable, knitted sensor vest that wirelessly transmits 12-lead ECG equivalent data to a smartphone. The vest’s conductive yarns, coated with reduced graphene oxide, maintained signal integrity after 50 wash cycles.

Another notable advance is the development of microneedle patches for continuous glucose monitoring (CGM) without interstitial fluid lag. A 2025 paper inNature Biomedical Engineeringdescribed a hollow microneedle array integrated with an enzymatic biosensor and a Bluetooth Low Energy (BLE) chip. The device achieved a mean absolute relative difference (MARD) of 8.2% compared to venous blood glucose, and its on-skin lifetime was extended to 14 days through a hydrogel-based enzyme stabilization layer. This eliminates the need for frequent sensor replacement, a major barrier to CGM adoption in type 2 diabetes.

4. Edge Computing and Decentralized Data Processing To address privacy concerns and reduce bandwidth demands, edge computing has become a critical enabler. Instead of streaming raw data to the cloud, modern systems perform feature extraction and classification locally. A 2024 implementation by Liu et al. used a Raspberry Pi Pico with a custom RISC-V accelerator to run a random forest model for fall detection. The device achieved a latency of 15 ms from fall event to alert generation, with zero data leaving the home network. This architectural shift is particularly important for elderly populations who may be wary of cloud-based surveillance.

Federated learning (FL) further enhances privacy by training models across multiple edge devices without centralizing raw data. A multi-center study by Ahmed et al. (2025) applied FL to predict exacerbations in chronic obstructive pulmonary disease (COPD) using data from 1,500 patients across 10 hospitals. The FL model achieved an area under the curve (AUC) of 0.87, comparable to a centrally trained model, while ensuring that patient data never left local servers. This approach is now being extended to cardiac implantable electronic devices (CIEDs) to enable remote firmware updates and algorithm personalization.

5. Wireless Communication: Low-Power, Long-Range Protocols The choice of wireless protocol significantly impacts battery life and coverage. While BLE remains dominant for short-range wearables, long-range technologies like LoRaWAN and NB-IoT are gaining traction for home-based monitoring. A 2024 field trial in rural India demonstrated that a LoRaWAN-based pulse oximeter could transmit SpO2 and heart rate data to a clinic 15 km away with a battery life of 18 months using a single AA cell. The system used adaptive data rate (ADR) to reduce transmission power when signal quality was high, further extending battery life.

For implantable devices, the Medical Implant Communication Service (MICS) band (402–405 MHz) is being supplemented by ultra-wideband (UWB) for high-data-rate applications. A 2025 study by Zhao et al. showed that UWB-based neural recording implants could stream 64-channel electrocorticography (ECoG) data at 10 Mbps with a power consumption of 2.3 mW, enabling real-time brain-computer interface (BCI) applications for paralyzed patients.

6. Clinical Validation and Real-World Adoption The translation of these technologies into clinical practice is accelerating. The U.S. Centers for Medicare & Medicaid Services (CMS) expanded reimbursement codes for RPM in 2024, covering up to 20 days of continuous monitoring per month. A randomized controlled trial by the Mayo Clinic (2024) found that RPM combined with AI-driven coaching reduced 30-day readmission rates for heart failure patients by 34% compared to standard care. The system used a Bluetooth-enabled scale, blood pressure cuff, and a smartwatch that provided step count and sleep quality metrics.

In infectious disease surveillance, remote monitoring played a pivotal role during the 2024 mpox outbreak. A wearable thermometer patch developed by the University of Oxford detected fever onset 48 hours before clinical diagnosis in 89% of cases, triggering automated contact tracing and self-isolation alerts. This demonstrated the potential of RPM as a first line of defense against emerging pathogens.

7. Challenges and Future Directions Despite these advances, several barriers remain. Interoperability between proprietary devices and electronic health records (EHRs) is still limited. The Fast Healthcare Interoperability Resources (FHIR) standard is being adopted, but many legacy systems lack APIs for real-time data ingestion. Additionally, health equity concerns arise because low-income populations may lack access to smartphones or reliable internet. Solar-powered, offline-capable devices with SMS-based data transmission are being tested in sub-Saharan Africa.

Looking ahead, the integration of digital twins will revolutionize remote monitoring. A digital twin—a virtual replica of a patient’s physiology—can simulate disease progression and treatment responses using real-time sensor data. Early work by the European Union’s DigiTwins project has demonstrated that a digital twin of a type 1 diabetes patient can predict hypoglycemic events 30 minutes in advance with 95% accuracy, enabling preemptive insulin adjustments.

Another frontier is the use of ambient sensors (e.g., radar, lidar) for non-contact monitoring. Researchers at MIT have developed a wall-mounted radar system that detects falls, breathing patterns, and even cardiac arrest without any wearable device. While still in prototype stage, such systems could serve as a passive safety net for elderly individuals who forget to wear their sensors.

8. Conclusion Remote monitoring has evolved from a niche convenience to a clinically validated, AI-driven ecosystem. The convergence of low-power edge AI, stretchable sensors, and long-range wireless protocols is enabling proactive, equitable, and personalized healthcare. As regulatory frameworks mature and interoperability improves, remote monitoring will become an integral component of precision medicine, shifting healthcare from reactive treatment to continuous prevention. The next decade will likely see the emergence of closed-loop systems that not only monitor but also autonomously intervene—a true realization of the “hospital at home” vision.

References